CARE has got feedback from Gensol’s lenders that there have been delays in the servicing of term loan obligation and hence the downgrade from BB+ to D.
- Company had an outstanding debt of Rs 1,150 cr as at December 31, 2024.
- It had negative operating cash flows during FY 24. During the current year, the situation continues to remain muted.
- Major lenders to the Company include Indian Renewable Energy Development Agency (IREDA), Power Finance Corporation (PFC), Bandhan Bank, ICICI Bank, and HDFC Bank.
Company is trying to reduce debt (through asset sale) and claims that it’s on the right track to do so gradually. Difficult to rely on these predictions.
Management has provided following key comments on the issue.
As regards BlueSmart subsidiary, Company claims that all the debt obligation are being paid on time and the funding round of Rs 400 is closed. 75% has already come in and balance 25% will come in near term.
Promoters have army background. They came on TV to explain in detail. Responses seemed ok but over bullish (lenders committed to not dump the stock, 90 day rating upgrade, huge order book, timeline to execute these orders etc). Their capability to manage finances is a key monitorable.